LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

NCT00936611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom's Macroglobulinemia

Interventions

DRUG: LBH589

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]